Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thriftmaster Texas is a Texas company operating under the ThriftMaster Global Holdings and Thriftmaster Global Biosciences names, focused on cannabidiol-based products and an inhalation delivery platform called ApelinDx. The company says it is developing proprietary CBD formulations administered through a metered-dose inhaler for potential use across inflammatory, neurologic, oncologic, pain, and addiction-related conditions. Its public materials emphasize sponsored academic research, preclinical studies, and preparation for early-stage human testing rather than an established commercial prescription-drug pipeline. The company has also marketed consumer CBD products, and in December 2022 the FDA issued a warning letter alleging that several of its CBD products were unapproved and misbranded. Overall, it appears to be an early-stage cannabinoid therapeutics and device-focused company rather than a conventional clinical-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thriftmaster Texas.